Impact of select risk factors on treatment outcome in adults with candidemia
Author(s) -
Brandon Hill,
Richard H. Drew,
Dustin Wilson
Publication year - 2019
Publication title -
pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 24
eISSN - 1886-3655
pISSN - 1885-642X
DOI - 10.18549/pharmpract.2019.3.1561
Subject(s) - medicine , neutropenia , concomitant , odds ratio , regimen , fluconazole , intensive care unit , cohort , intensive care medicine , pediatrics , chemotherapy , antifungal , dermatology
Treatment failure, receipt of concomitant RRT, and neutropenia were infrequent in patients undergoing treatment for candidemia. In our cohort, exposure to RRT, a fluconazole monotherapy regimen, ICU stay, or neutropenia during treatment did not impact treatment outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom